Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Pfizer Inc (PFE)

Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Pfizer Inc 66 HUDSON BOULEVARD EAST NEW YORK NY 10001 USA

www.pfizer.com Employees: 81,000 P: 212-733-2323

Sector:

Medical

Description:

Pfizer Inc. is a research-based, global biopharmaceutical company. The company boasts a sustainable pipeline with multiple late-stage programs that can drive growth. Pfizer markets a wide range of drugs and vaccines. Its business comprises six business units - Oncology, Inflammation & Immunology, Rare Disease, Hospital, Vaccines and Internal Medicine. Pfizer spinned-off its Upjohn unit, its off-patent branded and generic established medicines business, and combined it with generic drugmaker Mylan to create a new generic pharmaceutical company called Viatris. The Consumer Healthcare (CHC) segment, an over-the-counter (OTC) medicines business, was merged with Glaxo's unit to form a new joint venture.'The Consumer Healthcare joint venture with Glaxo and the merger of Upjohn unit with Mylan has made Pfizer a smaller company with a diversified portfolio of innovative drugs and vaccines.

Key Statistics

Overview:

Market Capitalization, $K 157,664,672
Enterprise Value, $K 220,972,672
Shares Outstanding, K 5,685,708
Float, K 5,682,297
% Float 99.94%
Short Interest, K 129,802
Short Float 2.28%
Days to Cover 2.73
Short Volume Ratio 0.45
% of Insider Shareholders 0.06%
% of Institutional Shareholders 68.36%

Financials:

Annual Sales, $ 62,579 M
Annual Net Income, $ 7,771 M
Last Quarter Sales, $ 17,557 M
Last Quarter Net Income, $ -1,648 M
EBIT, $ 19,118 M
EBITDA, $ 26,131 M

Growth:

1-Year Return 8.21%
3-Year Return -35.83%
5-Year Return -19.48%
5-Year Revenue Growth 49.32%
5-Year Earnings Growth 45.05%
5-Year Dividend Growth -50.72%

Per-Share Information:

Most Recent Earnings 0.66 on 02/03/26
Next Earnings Date 05/05/26
Earnings Per Share ttm 3.23
EPS Growth vs. Prev Qtr -24.14%
EPS Growth vs. Prev Year 4.76%
Annual Dividend & Yield (Paid) 1.72 (6.20%)
Annual Dividend & Yield (Fwd) 1.72 (6.36%)
Most Recent Dividend 0.430 on 01/23/26
Next Ex-Dividends Date 01/23/26
Dividend Payable Date 03/06/26
Dividend Payout Ratio 53.10%
Most Recent Split 3-1 on 07/01/99

PFE Ratios

Ratio
Price/Earnings ttm 8.55
Price/Earnings forward 9.09
Price/Earnings to Growth N/A
Return-on-Equity % 20.25%
Return-on-Assets % 8.87%
Profit Margin % 12.42%
Debt/Equity 0.66
Price/Sales 2.51
Price/Cash Flow 6.61
Price/Book 1.65
Book Value/Share 16.37
Interest Coverage -1.49
60-Month Beta 0.47

PFE Dividends

Date Value
01/23/26 $0.4300
11/07/25 $0.4300
07/25/25 $0.4300
05/09/25 $0.4300
01/24/25 $0.4300
11/08/24 $0.4200
07/26/24 $0.4200
05/09/24 $0.4200
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar